Moving Center Stage: patients claim their role in healthcare

Balz V, Klöppel U, Hulverscheidt M, et al. Arzneimittel des 20. Jahrhunderts: Historische Skizzen von Lebertran bis Contergan (Science Studies) (Paperback)(German) - Common. Transcript Verlag, 2009

Crimp D. Before Occupy: How AIDS Activists Seized Control of the FDA in 1988. The Atlantic 2011. Available at: http://www.theatlantic.com/health/archive/2011/12/before-occupy-how-aids-activists-seized-control-of-the-fda-in-1988/249302/ (Last accessed March 2016)

Rosenberg W, Donald A. Evidence based medicine: an approach to clinical problem-solving. BMJ 1995; 310: 1122-6; http://dx.doi.org/10.1136/bmj.310.6987.1122

Henshall C, Koch P, von Below GC, et al. Health Technology Assessment in Policy and Practice. Int J Technol Assess Health Care 2002; 18: 447-55; http://dx.doi.org/10.1017/S0266462302000302

Cuche M, Beckerman R, Chowdhury CA, et al. Early dialogue with health technology assessment bodies: a European perspective. Int J Technol Assess Health Care 2014; 30: 571-8; http://dx.doi.org/10.1017/S0266462314000713

EMA. European Medicines Agency – Patients and consumers. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/partners_and_networks/general/general_content_000317.jsp&mid=WC0b01ac058003500c (Last accessed March 2016)

Hoos A, Anderson J, Boutin M, et al. Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action. Ther Innov Regul Sci 2015; 49: 929-39; http://dx.doi.org/10.1177/2168479015580384

EULAR Secretariat, Switzerland. EULAR Standing Committee of PARE. Available at: http://www.eular.org/myUploadData/files/PARE_Values_Principles_web.pdf (Last accessed March 2016)

Pushparajah D, Geissler J, Westergaard N. EUPATI: Collaborating between patients, academia and industry to champion the informed patient in medicines research and development. J Med Dev Sci 2015; 1 Available at http://jmds.whioce.com/index.php/journal-of-medicines-development/article/view/01011 (Last accessed March 2016)

Forst T, Hohberg C, Schöndorf T, et al. Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the FlexPen device. Diabetes Technol Ther 2009; 11: 87-92; http://dx.doi.org/10.1089/dia.2008.0039

Holtorf AP, Palacios D, Brixner DI. The Role of Patients in Clinical Research and Evidence Based Decision Making as Reported Via a Survey of Patient Advocates. Value in Health 2014; 17: A435; http://dx.doi.org/10.1016/j.jval.2014.08.1119

Buck D, Gamble C, Dudley L, et al. From plans to actions in patient and public involvement: qualitative study of documented plans and the accounts of researchers and patients sampled from a cohort of clinical trials. BMJ Open 2014; 4: e006400; http://dx.doi.org/10.1136/bmjopen-2014-006400

Gamble C, Dudley L, Allam A, et al. An evidence base to optimise methods for involving patient and public contributors in clinical trials: a mixed-methods study. Southampton (UK): NIHR Journals Library, 2015

Dudley L, Gamble C, Preston J, et al. What Difference Does Patient and Public Involvement Make and What Are Its Pathways to Impact? Qualitative Study of Patients and Researchers from a Cohort of Randomised Clinical Trials. PLoS ONE 2015; 10: e0128817; http://dx.doi.org/10.1371/journal.pone.0128817

Carvel D. Patient-partners may be political correctness gone too far. BMJ 1999; 319: 783-4

AFM-Téléthon. Available at: http://www.afm-telethon.fr/home (Last accessed March 2016)

Dunkle M, Pines W, Saltonstall PL. Advocacy groups and their role in rare diseases research. Adv Exp Med Biol 2010; 686: 515-25; http://dx.doi.org/10.1007/978-90-481-9485-8_28

Staniszewska S, Crowe S, Badenoch D, et al. The PRIME project: developing a patient evidence-base. Health Expect 2010; 13: 312-22; http://dx.doi.org/10.1111/j.1369-7625.2010.00590.x